Bonsai Research is expanding its RX Health division (prescription drugs). Jörg Paus, a proven expert in pharmaceutical and healthcare research, is joining the team. Real behavioral data from 20 million online users enables Bonsai to conduct AI-powered in-depth analyses of the sensitive topic of the patient journey.

– The highlight of the " Bonsai" offering: the combination of behavioral data with actual sales data from the pharmacies’ inventory management systems.

Bonsai Bonsai is launching its AI Development Team as a new organizational unit. In this way, is leveraging its behavioral data science expertise to consistently continue its growth trajectory through the use of artificial intelligence. The new “ ” logo is the logical outcome of the evolution of AI projects into scalable processes. Bonsai

Bonsai Research launches the new bonsAI today after extensive testing. bonsAI is a state-of-the-art, AI-powered marketing and market research solution that will revolutionize the way companies understand and interact with their audiences. By analyzing online behavioral data from 20 million online users worldwide, bonsAI creates detailed audience profiles and transforms this data into actionable insights using Knowledge Graphs and Large Language Models (LLMs). In Germany alone, bonsAI has access to the data of 500,000 online users. bonsAI makes concrete suggestions for channels, content and even for visuals and the language style of campaigns.

The analytics team at Bonsai is being expanded by a strong trio. First and foremost, top expert Renate Drees, who can draw on more than 30 years of expertise in this field. Renate Drees joins Bonsai as Senior Research Analyst; she was previously with Kantar. The two other new additions to the analyst team: Mario Trosien and Marcel Kügler.